Advertisement

Strongyloides stercoralis

  • Vassil St. Georgiev
Chapter
  • 120 Downloads
Part of the Infectious Disease book series (ID)

Abstract

Strongyloides stercoralis, the causative agent of strongyloidiasis, is an intestinal nematod classified in the genus Strongyloides. The latter are plasmids widely distributed as intestinal parasites in mammals. S. stercoralis (known also as S. intestinalis, Anguillula intestinalis, A. stercoralis) is a roundworm occuring mainly in tropical and subtropical countries (1). In the U. S., strongyloidiasis is endemic in certain southern regions (eastern Kentucky, Tennessee, Lousiana, and southern Appalachia) (2–4), although cases have been reported in all major geographic areas of the country (2,3,5–18), with fatal outcomes being reported in malnourished children from socioeconomically deprived circumstances (13,19,20).

Keywords

Adult Respiratory Distress Syndrome Immunosuppressed Patient Lepromatous Leprosy Tuberculoid Leprosy Hyperinfection Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Genta, R. M. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev. Infect. Dis, 11, 755, 1989.PubMedCrossRefGoogle Scholar
  2. 2.
    Fulmer, H. S. and Huempfner, H. R. Intestinal helminths in eastern Kentucky: a survey in rural counties. Am. J. Trop. Med. Hyg, 14, 269, 1965.PubMedGoogle Scholar
  3. 3.
    Ophüs, W. A fatal case of strongyloidiasis in man, with autopsy. Arch. Pathol, 8, 1, 1929.Google Scholar
  4. 4.
    Berk, S. L., Verghese, A., Alvarez, S., Hall, K., and Smith, B. Clinical and epidemiologic features of strongyloidiasis: a prospective study in rural Tennessee. Arch. Intern. Med, 147, 1257, 1987.PubMedCrossRefGoogle Scholar
  5. 5.
    Scowden, E. B., Schaffner, W., and Stone, W. J. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore), 57, 527, 1978.Google Scholar
  6. 6.
    Igra-Siegman, Y., Kapila, R., Sen, P., Kaminski, Z. C., and Louria, D. B. Syndrome of hyperinfection with Strongyliodes stercoralis. Rev. Infect. Dis, 3, 397, 1981.CrossRefGoogle Scholar
  7. 7.
    Pollock, T. W. and Perencevich, E. N. Hyperinfection with Strongyloides stercoralis in a patient with Hodgkin’s disease. J. Am. Ostheopath. Assoc, 76, 171, 1976.Google Scholar
  8. 8.
    Rogers, W. A. Jr. and Nelson, B. Strongyloidiasis and malignant lymphoma:“opportunistic infection” by a nematode. J. Am. Med. Assoc, 195, 685, 1966.CrossRefGoogle Scholar
  9. 9.
    Buss, D. H. Strongyliodes stercoralis infection complicating granulocytic leukemia. N. C. Med. J, 32, 269, 1971.PubMedGoogle Scholar
  10. 10.
    Civantos, F. and Robinson, M. J. Fatal strongyloidiasis following corticosteroid therapy. Am. J. Dig. Dis, 14, 643, 1969.PubMedCrossRefGoogle Scholar
  11. 11.
    Cahill, K. M. Thiabendazole in massive strongyloidiasis. Am. J. Trop. Med. Hyg, 16, 451, 1967.Google Scholar
  12. 12.
    Amir-Ahmadi, H., Braun, P., Neva, F. A., Gottlieb. L. S., and Zamcheck, N. Strongyloidiasis at the Boston City Hospital. Am. J. Dig. Dis, 13, 959, 1968.Google Scholar
  13. 13.
    Smith, S. B., Schwartzman, M., Mencia, L. F., et al. Fatal disseminated strongyloidiasis presenting as acute abdominal distress in an urban child. J. Pediatr, 91, 607, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Seabury, J. H., Abadie, S., and Savoy, F. Jr. Pulmonary strongyloidiasis with lung abscess: ineffectiveness of thiabendazole therapy. Am. J. Trop. Med. Hyg, 20, 209, 1971.PubMedGoogle Scholar
  15. 15.
    Cuni, L., Rosner, F., and Chawla, S. K. Fatal strongyloidiasis in immunosuppressed patients. NY State J. Med, 77, 2109, 1977.Google Scholar
  16. 16.
    Cummins, R. O., Suratt, P. M., and Horwitz, D. A. Disseminated Strongyloides stercoralis infection. Arch. Intern. Med, 138, 1005, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Berger, R., Kraman, S., and Paciotti, M. Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am. J. Trop. Med. Hyg, 29, 31, 1980.PubMedGoogle Scholar
  18. 18.
    Milder, J. E., Walzer, P. D., Kilgore, G., Rutherford, I., and Klein, M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology, 80, 1481, 1981.PubMedGoogle Scholar
  19. 19.
    Cookson, J. B., Montgomery, R. D., Morgan, H. V., and Tudor, R. W. Fatal paralytic ileus due to strongyloidiasis. Br. Med. J, 4, 771, 1972.PubMedCrossRefGoogle Scholar
  20. 20.
    Huchton, P. and Horn, R. Strongyloidiasis. J. Pediatr, 55, 602, 1959.PubMedCrossRefGoogle Scholar
  21. 21.
    Faust, E. C. and DeGroat, A. Internal autoinfection in human strongyloidiasis. Am. J. Trop. Med, 20, 359, 1940.Google Scholar
  22. 22.
    Galliard, H. Pathogenesis of Strongyloides. Helminthol. Abstr, 36, 247, 1967.Google Scholar
  23. 23.
    Purtilo, D. T., Meyers, W. M., and Connor, D. H. Fatal strongyloidiasis in immunosuppressed patients. Am. J. Med, 56, 488, 1974.PubMedCrossRefGoogle Scholar
  24. 24.
    Adam, M., Morgan, O., Persaud, C., and Gibbs, W. N. Hyperinfection syndrome, with Strongyloides stercoralis in malignant lymphoma. Br. Med. J, 1, 264, 1973.PubMedCrossRefGoogle Scholar
  25. 25.
    Ali-Khan, Z. and Seemayer, T. A. Fatal bowel infaction and sepsis: an unusual complication of systemic strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg, 69, 473, 1975.PubMedCrossRefGoogle Scholar
  26. 26.
    Brown, H. W. and Perna, V. P., An overwhelming Strongyloides infection. J. Am. Med. Assoc, 168, 1648, 1958.PubMedCrossRefGoogle Scholar
  27. 27.
    Cruz, T., Reboucas, G., and Rocha, H. Fatal strongyloidiasis in patients receiving corticosteroids. N. Engl. J. Med, 275, 1093, 1966.PubMedCrossRefGoogle Scholar
  28. 28.
    Kuberski, T. T., Gabor, E. P., and Boudreaux, D. Disseminated strongyloidiasis: a complication of the immunosuppressed host. West. J. Med, 122, 504, 1975.PubMedGoogle Scholar
  29. 29.
    Higenbottam, T. W. and Heard, B. E. Opportunistic pulmonary strongyloidiasis complicating asthma treated with steroids. Thorax, 31, 226, 1976.PubMedCrossRefGoogle Scholar
  30. 30.
    Liepman, M. Disseminated Strongyloides stercoralis, a complication of immunosuppression. J. Am. Med. Assoc, 231, 287, 1975.CrossRefGoogle Scholar
  31. 31.
    Cadham, F. T. Infestation with Strongyloides stercoralis associated with severe symptoms. Can. Med. Assoc. J, 29, 18, 1933.PubMedGoogle Scholar
  32. 32.
    Aziz, E. M. Strongyloides stercoralis infestation: review of the literature and report of 33 cases. South. Med. J, 62, 806, 1969.PubMedCrossRefGoogle Scholar
  33. 33.
    Rojas, R. A. M. Pathology of Protozoal and Helminthic Diseases. Williams & Wilkins, Baltimore, 713, 1971.Google Scholar
  34. 34.
    Scaglia, M., Brustia, R., Gatti, S., et al. Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases. Bull. Soc. Pathol. Exot. Filiales, 77, 328, 1984.PubMedGoogle Scholar
  35. 35.
    Genta, R. M., Gatti, S., Linke, M. J., Cevini, C., and Scaglia, M. Endemic strongyloidiasis in northern Italy: clinical and immunological aspects. Q. J. Med, 258, 679, 1988.Google Scholar
  36. 36.
    Davidson, R. A. Strongyloidiasis: a presentation of 63 cases. N. C. Med. J, 43, 23, 1982.PubMedGoogle Scholar
  37. 37.
    Davidson, R. A., Fletcher, R. H., and Chapman, L. E. Risk factros for strongyloidiasis: a case-control study. Arch. Intern. Med, 144, 321, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Rivera, E., Maldonado, N., Velez-Garcia, E., Grillo, A. J., and Malaret, G. Hyperinfection syndrome with Strongyloides stercoralis. Ann. Intern. Med, 72, 199, 1970.Google Scholar
  39. 39.
    Keller, R. and Keist, R. Protective immunity to Nippostrongylus brasiliensis in the rat: central role of the lymphocyte in worm expulsion. Immunology, 22, 767, 1972.PubMedGoogle Scholar
  40. 40.
    Neva, F. A. Biology and immunology of human strongyloidiasis. J. Infect. Dis, 153, 397, 1986.PubMedCrossRefGoogle Scholar
  41. 41.
    Genta, R. M. Strongylodes stercoralis: immunobiological considerations on an unusual worm. Parasitology Today, 2, 241, 1986.PubMedCrossRefGoogle Scholar
  42. 42.
    Wong, B. Parasitic diseases in immunocompromised hosts. Am. J. Med, 76, 479, 1984.CrossRefGoogle Scholar
  43. 43.
    Longworth, D. L. and Weller, P. F. Hyperinfection syndrome with strongyloidiasis, in Current Clinical Topics in Infectious Diseases, Remington, J. S. and Swartz, M. N., Eds., McGraw-Hill, New York, 1, 1986.Google Scholar
  44. 44.
    Willis, A. J., P. and Nwokolo, C. Steroid therapy and strongyloidiasis. Lancet, 1, 1396, 1966.PubMedCrossRefGoogle Scholar
  45. 45.
    Smith, J. W. Strongyloidiasis. Clin. Microbiol. Newsletter, 13, 33, 1991.CrossRefGoogle Scholar
  46. 46.
    Armstrong, D. and Paredes, J. Strongyloidiasis, in Respiratory Disease in the Immunocompromised Host, Shalamer, J., Pizzo, P. A., Parrillo, J. E., and Masur, H., Eds. J. B. Lippincott, Philadelphia, 428, 1991.Google Scholar
  47. 47.
    Karolyi, Z., Eros, N., and Kriston, R. Cutaneous manifestations of strongyloidosis. Orv. Hetil 140, 191–194, 1999.PubMedGoogle Scholar
  48. 48.
    Hanck, Ch. and Holzer, B. R. Strongyloidiasis unter immunosuppressiver therapy. Schweiz. Med. Wcshr, 122, 899, 1992.Google Scholar
  49. 49.
    Stewart, J. B. and Heap, B. J. Fatal disseminated strongyloidiasis in an immunocompromised former war prisoner of the Japanese. J. R. Army Med. Corps,131, 47, 1985Google Scholar
  50. 50.
    Rivals, A., Rouquet, R. M., Recco, P., Linas, M. D., Leophonte, P., and Didier, A. A rare cause of asthma exacerbation: systemic anguilluliasis. Rev. Mal. Respir, 17, 99–102, 2000.PubMedGoogle Scholar
  51. 51.
    Thomas, M. C. and Costello, S. A. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int. J. Clin. Pract, 52, 520–521, 1998.PubMedGoogle Scholar
  52. 52.
    Suvajdzic, N., Kranjcic-Zec, I., Jovanovic, V., Popovic, D., and Colovic, M. Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap.), 29, 323–326, 1999.Google Scholar
  53. 53.
    Link, K. and Orenstein, R. Bacterial complications of strongyloidiasis: Streptococcus bovin meningitis. South Med. J, 92, 728–731, 1999.PubMedCrossRefGoogle Scholar
  54. 54.
    Suvajdzic, N., Kranjcic-Zec, I., Jovanovic, V., Popovic, D., and Colovic, M. Fatal strongyloidosis following corticosteroid therapy in a patient with chronic idiopathic thrombocytopenia. Haematologia (Budap), 29, 323–326, 1999.Google Scholar
  55. 55.
    Batoni, F. L., Ianhez, L. E., Saldanha, L. B., and Sabbaga, E. Acute respiratory insufficiency caused by disseminated strongyloidiasis in a renal transplant. Rev. Inst. Ned. Trop. Sao Paulo, 18, 283, 1976.Google Scholar
  56. 56.
    Fagundes, L. A., Busato, O., and Brentano, L. Strongyloidiasis: fatal complication of renal transplantation. Lancet, 2, 439, 1971.CrossRefGoogle Scholar
  57. 57.
    Meyers, A. M., Shapiro, D. J., Milne, F. J., Myburgh, J. A., and Rabkin, R. Strongyloides stercoralis hyperinfection in a renal allograft recipient. S. Afr. Med. J, 50, 1301, 1976.PubMedGoogle Scholar
  58. 58.
    Scoggin, C. H. and Call, N. B. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann. Intern. Med, 87, 456, 1977.PubMedGoogle Scholar
  59. 59.
    DeVault, G. A., King, J. W., Rohr, M. S., Landreneau, M. D., Brown, S.T. III, and McDonald, J. C., Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev. Infect. Dis, 12, 653, 1990.CrossRefGoogle Scholar
  60. 60.
    Palau, L. A. and Pankey, G. A. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am. J. Trop. Med. Hyg, 57, 413–415, 1997.PubMedGoogle Scholar
  61. 61.
    Dwork, K. G., Jaffe, J. R., and Lieberman, H. D. Strongyloidiasis with massive hyperinfection. NY State J. Med, 75, 1230, 1975.Google Scholar
  62. 62.
    Neefe, L. I., Pinilla, O., Garagusi, V. F., and Bauer, H. Disseminated strongyloidiasis with cerebral involvement. Am. J. Med, 55, 832, 1973.Google Scholar
  63. 63.
    Said, S., Nevez, G., Moriniere, P., Fournier, A., and Raccurt, C. P. Hemodialyse et strongyloidose: une cause presumee d’hypereosinophilie peut en cacher une autre. Nephrologie, 20, 343–346, 1999.PubMedGoogle Scholar
  64. 64.
    Ho, P. L., Luk, W. K., Chan, A. C., and Yuen, K. Y. Two cases of fatal stroingyloidiasis in Hong Kong. Pathology, 29, 324–326, 1997.PubMedCrossRefGoogle Scholar
  65. 65.
    Emad, A. Exudative eosinophilic pleural effusion due to Strongyloides stercoralis in a diabetic man. South. Med. J, 92, 58–60, 1999.PubMedCrossRefGoogle Scholar
  66. 66.
    Bozikov, V., Dzebro, S., Seidle, K., Dominis, M., Zambal, Z., and Skrabalo, Z. Fatal “overwhelming” strongyloidiasis in an immunosuppressed patient. Lijec Vjesn, 118, 23–26, 1996.PubMedGoogle Scholar
  67. 67.
    Nagalotimath, S. J., Ramaprasad, A. V., and Chandrashekhar, N. K. Fatal strongyloidiasis in a patient receiving corticosteroids. Indian J. Pathol. Bacteriol, 17, 190, 1974.PubMedGoogle Scholar
  68. 68.
    Yim, Y., Kikkawa, Y., Tanowitz, H., and Wittner, M. Fatal strongyloidiasis in Hodgkin’s disease after immunosuppressive therapy. J. Trop. Med. Hyg, 73, 245, 1970.PubMedGoogle Scholar
  69. 69.
    Rassiga, A. L., Lowry, J. L., and Forman, W. B. Diffuse pulmonary due to Strongyloides stercoralis. J. Am. Med. Assoc, 230, 426, 1974.CrossRefGoogle Scholar
  70. 70.
    Suzuki, T., Nara, N., Miyake, S., Eishi, Y., Sugiyama, E, and Aoki, N. Fatal strongyloidiasis latent over 42 years in the antineoplastic chemotherapy of a case with malignant lymphoma. Jpn. J. Med, 28, 96, 1989.PubMedCrossRefGoogle Scholar
  71. 71.
    Patil, P., Jayshree, R. S., Acharya, R. S., Sridhar, H., Babu, G., and Suresh, T. M. Fulminant fatal Strongylides stercoralis infection in a post-chemotherapy immunosuppressed cancer patient. Med. Pediatr. Oncol, 33, 504–555, 1999.PubMedCrossRefGoogle Scholar
  72. 72.
    Daubenton, J. D., Buys, H. A., and Hartley, P. S. Disseminated strongyloidiasis in a child with lymphoblastic lymphoma. J. Pediatr. Hematol. Oncol, 20, 260–263, 1998.PubMedCrossRefGoogle Scholar
  73. 73.
    Muller, A., Fatkenheuer, G., Salzberger, B., Schrappe, M., and Diehl, V. Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma. Dtsch. Med. Wochenschr, 123, 381–385, 1998.PubMedCrossRefGoogle Scholar
  74. 74.
    Graeff-Teixeira, C., Leite, C. S., Sperhacke, C. L., et al. Prospective study of strongyloidosis in patients with hematologic malignancies. Rev. Soc. Bras. Med. Trop, 30, 355–357, 1997.PubMedCrossRefGoogle Scholar
  75. 75.
    Hartz, P. H. Human strongyloidiasis with internal autoinfection. Arch. Pathol, 41, 601, 1946.Google Scholar
  76. 76.
    Yoeli, M., Most, H., Berman, H. H., and Scheinesson, G. P., II. The clinical picture and pathology of a massive Strongyloides infection in a child. Trans. R. Soc. Trop. Med. Hyg, 57, 346, 1963.PubMedCrossRefGoogle Scholar
  77. 77.
    Bistrian B. R., Sherman, M., Blackburn, G. L., Marshall, R., and Shaw, C. Cellular immunity in adult marasmus. Arch. Intern. Med, 137, 1408, 1977.PubMedCrossRefGoogle Scholar
  78. 78.
    Gage, J. G. A case of Strongyloides intestinalis with larvae in the sputum. Arch. Intern. Med, 7, 561, 1911.CrossRefGoogle Scholar
  79. 79.
    Tullis, D. C. H. Bronchial asthma associated with intestinal parasites. N. Engl. J. Med, 282, 370, 1970.PubMedCrossRefGoogle Scholar
  80. 80.
    Giannella, R. A., Broitman, S. A., and Zamcheck, N. Influence of gastric acidity on bacterial and parasitic enteric infections. Ann. Intern. Med, 78, 271, 1973.PubMedGoogle Scholar
  81. 81.
    Shikhobalova, N. P. and Semenova, N. E. On the problem of the clinical study and treatment of strongyloidiasis. Trop. Dis. Bull, 41, 411, 1944.Google Scholar
  82. 82.
    Parana, R., Portugal, M., Vitvitski, L., Cotrim, H., Lyra, L., and Trepo, C. Severe strongyloidiasis during interferon plus ribavirin therapy for chronic HCV infection. Eur. J. Gastroenterol. Hepatol, 12, 245–246, 2000.PubMedCrossRefGoogle Scholar
  83. 83.
    Gompels, M., Todd, J., Peters, B., Main, J., and Pinching, A. J. Disseminated strongyloidiasis in AIDS: uncommon but important. AIDS, 5, 329, 1991.Google Scholar
  84. 84.
    Torres, J. R., Isturiz, R., Murillo, J., Guzman M., and Contreras, R. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin. Infect. Dis, 17, 900, 1993.PubMedCrossRefGoogle Scholar
  85. 85.
    Heath, T., Riminton, S., Garsia, R., and Macleod, C. Systemic strongyloidiasis complicating HIV: a promising response to ivermectin. Int. J. STD AIDS, 7, 294–296, 1996.PubMedCrossRefGoogle Scholar
  86. 86.
    Chieffi, P. P., Chiattone, C. S., Feltrim, E. N., Alves, R. C., and Paschoalotti, M. A. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in Sao Paulo City, Brazil. Mem. Inst. Oswaldom Cruz, 95, 711–712, 2000.CrossRefGoogle Scholar
  87. 87.
    Sorensen, M., Andersen, O., Friis-Moller, A., and Kvinesdal, B. B. Fatal outcome of Strongyloides stercoralis infection in a patient with no previously known immunosuppression. Ugeskr. Laeger, 162, 2894–2895, 2000.PubMedGoogle Scholar
  88. 88.
    Oya, H., Mori, S., Tsuchihashi, H., et al. A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I). Nihon Kokyuki Gakkai Zasshi, 36, 262–267, 1998.PubMedGoogle Scholar
  89. 89.
    Bonnet, C., Vergne, P., Bertin, P., and Treves, R. Anguillulose associee a une infection par HTLV1. Presse Med, 28, 788, 1999.PubMedGoogle Scholar
  90. 90.
    Gotuzzo, E., Terashima, A., Alvarez, H., et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am. Trop. Med. Hyg, 60, 146–149, 1999.Google Scholar
  91. 91.
    Nakada, K., Kohakura, M., Komoda, H., and Hinuma, Y. High incidence of HTLV-I antibody in carriers of Strongyloides stercoralis. Lancet, 1, 633, 1984.CrossRefGoogle Scholar
  92. 92.
    Higashiyama, Y., Sakata, H., Obase, Y., et al. A case of bacterial emningitis induced by strongyloidiasis. Kansenshogaku Zasshi, 71, 680–683, 1997.PubMedGoogle Scholar
  93. 93.
    Foucan, L., Genevier, I., Lamaury, I., and Strobel, M. Meningite purulente aseptique chez deux patients co-infectes par HTLV-1 et Strongyloides stercoralis. Med. Trop. (Mars.), 57, 262–264, 1997.Google Scholar
  94. 94.
    Newton, R. C., Limpuangthip, P., Greenberg, S., Gam, A., and Neva, F. A. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am. J. Med, 92, 202, 1992.PubMedCrossRefGoogle Scholar
  95. 95.
    Yamaguchi, K., Matutes, E., Catovsky, D., Galton D. A. G., Nakada, K., and Takatsuki, K. Strongyloides stercoralis as candidate co-factor for HTLV-1-induced leukaegenesis. Lancet, 2, 94, 1987.PubMedCrossRefGoogle Scholar
  96. 96.
    Maayan, S., Wormser, G. P., Widerhorn, J., Sy, E. R., Kim, Y. H., and Ernst, J. A. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am. J. Med, 83, 945, 1987.PubMedCrossRefGoogle Scholar
  97. 97.
    Vieyra-Herrera, G., Becerril-Carmona, G., Padua-Gabriel, A., Jessurun, J., and Alonso-de Ruiz, P. Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Acta Cytologica, 32, 277, 1988.Google Scholar
  98. 98.
    Pialoux, G., Beriel, P., Caudron, J., Chousterman, M., and Meyrignac, C. Syndrome d’imminodépression acquise associé a une anduillulose sévere. Presse Med, 13, 1960, 1984.PubMedGoogle Scholar
  99. 99.
    René, E., Marche, C., Régnier, B., et al. Manifestations digestives du syndrome d’immunodéficience acquise (SIDA): étude chez 26 patients. Gastroenterol. Clin. Biol, 9, 327, 1985.PubMedGoogle Scholar
  100. 100.
    Baird, J. K., De Vinatea, M. L., Macher, A. M., Sierra, J. A. R., and Lasala, G. AIDS: case for diagnosis series. Milit. Med, 152, M17, 1987.Google Scholar
  101. 101.
    Hillyer, G. V. and Climent, C. Acquired immunodeficiency syndrome (AIDS) and parasitic disease in Puerto Rico. Bol. Asoc. Med. PR, 80, 312, 1988.Google Scholar
  102. 102.
    Petithory, J. C. and Derouin, F. AIDS and strongyloidiasis in Africa. Lancer, 1, 921, 1987.CrossRefGoogle Scholar
  103. 103.
    Gachot, B., Bouvet, E., Bure, A., et al. HIV infection and malignant strongyloidiasis. Rev. Prat, 40, 2129, 1990.PubMedGoogle Scholar
  104. 104.
    Goyal, S. B. Intestinal strongyloidiasis as eosinophilic pleural effusion. South. Med. J, 91, 768–769, 1998.PubMedCrossRefGoogle Scholar
  105. 105.
    Weight, S. C. and Barrie, W. W. Colonic Strongyloides stercoralis infection masquerading as ulcerative colitis. J. R. Coll. Surg. Edinb, 42, 202–203, 1997.PubMedGoogle Scholar
  106. 106.
    Ting, Y. M. Pulmonary strongyloidiasis; case report of 2 cases. Kaohsiung J. Med. Sci, 16, 269–274, 2000.PubMedGoogle Scholar
  107. 107.
    Kinjo, T., Tsuhako, K., Nakazato, I., et al. Extensive intra-alveolar haemorrhage caused by disseminated strongyloidiasis. Int. J. Parasitol, 28, 323–330, 1998.PubMedCrossRefGoogle Scholar
  108. 108.
    Woodring, J. H., Halfhill, H. 2nd, Berger, R., Reed, J. C., and Moser, N. Clinical and imaging features of pulmonary strongyloidiasis. South. Med. J, 89, 10–19, 1996.PubMedCrossRefGoogle Scholar
  109. 109.
    Levy, G. C., Kallas, E. G., and Ramos Moreira Leite, K. Disseminated Strongyloides stercoralis infection in an AIDS patient: the role of suppressive therapy. Braz. J. Infect. Dis, 1, 48–51, 1997.Google Scholar
  110. 110.
    Kiyuna, M., Toda, T., Tamamoto, T., et al. An autopsy case of periarteritis nodosa associated with disseminated strongyloidiasis. Rinsho Byori, 42, 883, 1994.PubMedGoogle Scholar
  111. 111.
    Jacob, C. I. and Patten, S. F. Strongyloides stercoralis infection presenting as generalized prurigo nodularis and lichen simplex chronicus. J. Am. Acad. Dermatol, 41 (2 Pt. 2), 357–361, 1999.PubMedCrossRefGoogle Scholar
  112. 112.
    Mori, S., Konishi, T., Matsuoka, K., et al. Strongyloidiasis associated with nephritic syndrome. Intern. Med, 37, 606610, 1998.Google Scholar
  113. 113.
    Wong, T. Y., Szeto, C. C., Lai, F. F., Mak, C. K., and Li, P. K. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron, 79, 333–336, 1998.PubMedCrossRefGoogle Scholar
  114. 114.
    Brocq, O., Breul, V., Agopian, V., et al. Reactive arthritis induced by Strongyloides stercoralis. Rev. Rhum. Engl. Ed, 63, 217–219, 1996.Google Scholar
  115. 115.
    Genta, R. M., Douce, R. W., and Walzer, P. D. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J. Clin. Microbiol, 23, 1099, 1986.PubMedGoogle Scholar
  116. 116.
    Pearson, R. D. and Guerrant, R. L. Strongyloides infections, in Hunter’s Tropical Medicine, 7th ed., Strickland, G. T., Ed. W. B. Saunders, Philadelphia, 706, 1991.Google Scholar
  117. 117.
    Spry, C. J. F. Eosinophils: A Comprehensive Review, and Guide to the Scientific and Medical Literature. Oxford University Press, Oxford, 1988.Google Scholar
  118. 118.
    Moro-Furlani, A. M. and Krieger, H. Familial analysis of eosinophilia caused by helminthic parasites. Genet. Epidemiol, 9, 185, 1992.PubMedCrossRefGoogle Scholar
  119. 119.
    Fisher, D., McCary, F., and Currie, B. Strongyloidiasis in the Northern Territory. Med. J. Aust, 159, 88, 1993.PubMedGoogle Scholar
  120. 120.
    Prociv, P. Strongyloidiasis in the Northern Territory. Med. J. Aust, 159, 636, 1993.PubMedGoogle Scholar
  121. 121.
    Savage, D., Foadi, M. Haworth, C., and Grant, A. Marked eosinophilia in an immunosuppressed patient with strongyloidiasis. J. Intern. Med, 236, 473, 1994.PubMedCrossRefGoogle Scholar
  122. 122.
    Sher, A. and Coffman, R. L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol, 10, 385, 1992.PubMedCrossRefGoogle Scholar
  123. 123.
    Thomson, A. W., Mathie, I. H., and Sewell, H. F. Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cell and large granular lymphocytes within lymphoid tissues. Immunology, 60, 383, 1987.PubMedGoogle Scholar
  124. 124.
    Gherman, I., Oproiu, A., Aposteneau, G., et al. Observations on 35 cases of strongyloidiasis hospitalized at a clinical digestive disease unit. Rev. Med. Interna, 41, 169, 1989.Google Scholar
  125. 125.
    Stey, C., Jost, J., and Lüthy, R. Extraintestinale strongyloidiasis bei erworbenem immunmangelsyndrom. Dtsch. Med. Wschr, 115, 1716, 1990.PubMedCrossRefGoogle Scholar
  126. 126.
    Azab, M. E., Mohamed, N. H., Salem, S. A., et al. Parasitic infections associated with malignancy and leprosy. J. Egypt. Soc. Parasitol, 22, 59, 1992.PubMedGoogle Scholar
  127. 127.
    Harley, J. P. and Gallicchio, V. Effect of cortisone on the establishment of Nippostrongylus brasiliensis in the rabbit. J. Parasitol, 56, 271, 1970.PubMedCrossRefGoogle Scholar
  128. 128.
    Moqbel, R. Effect of corticosteroids on experimental strongyloidiasis. Proc. Br. Soc. Parasitology. Parasitology, 69, xviii, 1974.Google Scholar
  129. 129.
    Ogilvie, B. M. Use of cortisone derivatives to inhibit resistance to Nippostrongylus brasiliensis and to study the fate of parasites in resistant hosts. Parasitology, 55, 723, 1965.PubMedCrossRefGoogle Scholar
  130. 130.
    Franz, K. H. Clinical trials with thiabendazole against human strongyloidiasis. Am. J. Trop. Med. Hyg, 12, 211, 1963.Google Scholar
  131. 131.
    Most, H. Treatment of common parasitic infections of man encountered in the United States (first of two parts). N. Engl. J. Med, 287, 495, 1972.PubMedCrossRefGoogle Scholar
  132. 132.
    Wehner, J. H. and Kirsch, C. M. Pulmonary manifestations of strongyloidiasis. Semir. Respir. Infect, 12, 122–129, 1997.Google Scholar
  133. 133.
    Gordon, S. M., Gal, A. A., Solomon, A. R., and Bryan, J. A. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J. Am. Acad. Dermatol, 31, 255, 1994.PubMedCrossRefGoogle Scholar
  134. 134.
    Kramer, M. R., Gregg, P., Goldstein, M., Llamas, R., and Krieger, B. P. Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage. South. Med. J, 83, 1226, 1990.PubMedCrossRefGoogle Scholar
  135. 135.
    Schumaker, J. D., Band, J. D., Lensmeyer, G. L., and Craig, W. A. Thiabendazole treatment of severe strongyloidiasis in a hemodialyzed patient. Ann. Intern. Med, 89, 644, 1978.PubMedGoogle Scholar
  136. 136.
    Royle, G., Fraser-Moodie, A., and Jones, M. W. Hyperinfection with Strongyloides stercoralis in Great Britain. Br. J. Surg, 61, 498, 1974.PubMedCrossRefGoogle Scholar
  137. 137.
    Eland, I. A., Kerkhof, S. C., Overbosch, D., Wismans, P. J., and Stricker, B. H. Cholestatic hepatis ascribed to the use of thiabendazole. Ned. Tijdschr. Geneeskd, 142, 1331–1334, 1998.PubMedGoogle Scholar
  138. 138.
    Skandrani, K., Richardet, J. P., Duvoux, C., Cherqui, D., and Zafrani, E. S. Hepatic transplantaion for severe ductopenia related to ingestion of thiabendazole. Gastroenterol. Clin. Biol, 21, 623–625, 1997.PubMedGoogle Scholar
  139. 139.
    Bush, A., Gabriel, R., Gatus, S. J., and Thornton, J. G. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft patient. Br. Med. J, 286, 52, 1983.CrossRefGoogle Scholar
  140. 140.
    Cook, G. A., Rodriguez, A., Silva, H., Rodriguez-Iturbe, B., and Bohorquez de Rodriguez, H. Adult respiratory distress secondary to strongyloidiasis. Chest, 92, 1115, 1987.Google Scholar
  141. 141.
    Thomson, J. R. and Berger, R. Fatal adult respiratory distress syndrome following successfull treatment of pulmonary strongyloidiasis. Chest, 99, 772, 1991.CrossRefGoogle Scholar
  142. 142.
    Berger, R., Kramm, S, and Paciotti, M. Pulmonary strongyloidiasis complicating therapy with corticosteroids. Am. J. Trop. Med. Hyg, 29, 31, 1980.Google Scholar
  143. 143.
    Thomson, J. R. and Berger, R. Strongyloides stercoralis infection: a review of 66 cases. South. Med. J, 82 (Suppl.), 7, 1989.CrossRefGoogle Scholar
  144. 144.
    Bidulph, J. Mebendazole and albendazole for infants. Pediatr. Infect. Dis. J, 5, 373, 1990.Google Scholar
  145. 145.
    Currie, B. Why does Australia have no national drug policy? Med. J. Aust, 157, 210, 1992.PubMedGoogle Scholar
  146. 146.
    Sreenivas, D. V., Kumar, A., Kumar, Y. R., Bharavi, C., Sundaram, C., and Gayathri, K., Intestinal strongyloidiasis; a rare opportunistic infection. Indian J. Gastroenterol, 16, 105–106, 1997.PubMedGoogle Scholar
  147. 147.
    Nandy, A., Addy, M., Patra, P., and Bandyopashyay, A. K. Fulminating strongyloidiasis complicating Indian kala-azar. Trop. Geogr. Med, 47, 139, 1995.PubMedGoogle Scholar
  148. 148.
    Naquira, C., Jimenez, G., Guerra, J. G., et al. Ivermectin for human strongyloidiasis and other intestinal helminthes. Am. J. Trop. Med. Hyg, 40, 304, 1989.PubMedGoogle Scholar
  149. 149.
    Adenusi, A. A. Cure by ivermectin of a chronic, persistent intestinal strongyloidosis. Acta Trop, 66, 163–167, 1997.PubMedCrossRefGoogle Scholar
  150. 150.
    Ashraf, M., Gue, C. L., and Baddour, L. M., Case report: strongyloidiasis refractory to treatment with ivermectin. Am. J. Med. Sci, 311, 178–179, 1996.PubMedCrossRefGoogle Scholar
  151. 151.
    Giannoulis, E., Arvanitakis, C., Zaphirolopoulos, A., Nakos, V., Karkavelas, G., and Haralambidis, S. Disseminated strongyloidiasis with uncommon manifestations in Greece. J. Trop. Med. Hyg, 89, 171, 1986.PubMedGoogle Scholar
  152. 152.
    Zaha, O., Hirata, T., Kinjo, F., and Saito, A. Strongyloidiasis–progress in diagnosis and treatment. Intern. Med, 39, 695–700, 2000.PubMedCrossRefGoogle Scholar
  153. 153.
    Toma, H., Sato, Y., Siroma, Y., Kobayashi, J., Shimabukuro, I., and Takara, M. Comparative studies on the efiicacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J. Trop. Med. Public Health, 31, 147–151, 2000.PubMedGoogle Scholar
  154. 154.
    Marti, H., Haji, H. J., Savioli, L., et al. A comparative trial of a single-dose ivermectin versus theree days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg, 55, 477–481, 1996.PubMedGoogle Scholar
  155. 155.
    Pitisuttithum, P., Supanaranond, W., and Chindanond, D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J. Trop. Med. Public Health, 26, 735–738, 1995.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Vassil St. Georgiev
    • 1
  1. 1.National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations